For how much time and with which dose of inhaled steroids it is possible to maintain asthma control? A randomized prospective study Source: Annual Congress 2010 - Managing asthma and allergic disease in children Year: 2010
Three-year prospective cohort study of growth in asthmatic children prescribed appropriate inhaled corticosteroid (ICS) doses Source: Eur Respir J 2004; 24: Suppl. 48, 614s Year: 2004
“Stepping down” in mild-to-moderate asthmatic children being well controlled while receiving low doses of inhaled corticosteroids (ICS): Daily vs. cyclical ICS administration (prospective, randomized, multicentre, open-label trial) Source: Annual Congress 2013 –Asthma treatment and management in children Year: 2013
The use of high-dose inhaled corticosteroids and add-on therapy in children in the UK: an observational study of 4332 patients Source: Annual Congress 2004 - New aspects of drug therapy in paediatric asthma Year: 2004
Asthma control with inhaled corticosteroid therapy: A real-world observational study Source: Annual Congress 2010 - Management of airway disease Year: 2010
High-dose inhaled corticosteroids and add-on therapy use in adults in the UK: an observational study of 22,027 patients Source: Annual Congress 2004 - Primary care: asthma Year: 2004
Inhaled corticosteroids downregulate SARS-CoV-2-related genes in COPD: results from a randomised controlled trial Source: Eur Respir J, 58 (1) 2100130; 10.1183/13993003.00130-2021 Year: 2021
Adherence to beclomethasone in children with persistent asthma in a low-income country: a randomized concurrent cohort study Source: Eur Respir J 2005; 26: Suppl. 49, 162s Year: 2005
Montelukast and steroid effects on airway function compared with steroid alone and placebo: a single blind, controlled study in asthmatic school children Source: Eur Respir J 2003; 22: Suppl. 45, 132s Year: 2003
The effect of low-dose corticosteroids and theophylline on the risk of acute exacerbations of COPD: the TASCS randomised controlled trial Source: Eur Respir J, 57 (6) 2003338; 10.1183/13993003.03338-2020 Year: 2021
Inhaled budesonide in the treatment of early COVID-19 illness: a randomised controlled trial Source: Virtual Congress 2021 – ALERT: bronchiectasis and COVID Year: 2021
Inhaled corticosteroids in patients with mild to moderate COPD with and without airway hyperresponsiveness to mannitol: A randomized placebo controlled trial Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011
Omalizumab in patients with moderate-to-severe persistent asthma poorly controlled on high-dose inhaled corticosteroids and long-acting beta-agonists: Results of a phase IIIb randomized controlled trial Source: Annual Congress 2010 - Aspects of severe asthma Year: 2010
Step-up of asthma therapy: an observational study comparing increased inhaled corticosteroid dosage to combination inhaled corticosteroid/long acting beta agonist therapy in UK general practice Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control Year: 2007
Treatment of patients with uncontrolled asthma using high dose inhaled corticosteroids administered by controlled inhalation – a retrospective analysis Source: Annual Congress 2009 - Aspects of uncontrolled asthma Year: 2009
Unlicensed use of high-dose inhaled corticosteroids in the UK occurs principally with fluticasone - an observational study of 26359 patients Source: Eur Respir J 2004; 24: Suppl. 48, 501s Year: 2004
Efficacy and safety of as-needed corticosteroid plus fast or short-acting beta-agonists monotherapy in patients with mild asthma: a meta-analysis of randomised controlled trials. Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma Year: 2020
Meta-analysis of inhaled corticosteroids response in children with asthma. Source: International Congress 2019 – Paediatric asthma: risk factors, biomarkers and the basics Year: 2019
Reframing asthma and inhaled corticosteroids (ICS) to modify treatment beliefs: an online randomised controlled trial Source: International Congress 2018 – Educational tools to improve your practice Year: 2018
LATE-BREAKING ABSTRACT: A dose-ranging study of dupilumab in patients (pts) with uncontrolled asthma despite use of inhaled corticosteroids plus a long-acting beta-agonist (ICS/LABA): Final data Source: International Congress 2015 – Hot topics on airway diseases: new horizons in treatment Year: 2015